Skip to main content

Table 3 Outcomes of 203 lung transplant recipients

From: Analysis of sex-based differences in clinical and molecular responses to ischemia reperfusion after lung transplantation

 

Overall (n = 203)

Male (n = 122)

Female (n = 81)

p value

Primary outcomes

 PGD3 at T48

54 (27)

39 (32)

15 (19)

0.050

 PGD3 at T72

47 (23)

30 (25)

17 (21)

0.670

 PGD decrease from T0 to T72

61 (30)

30 (25)

31 (38)

0.087

 PGD difference from T72 to T0

 − 0.084 ± 0.95

0.016 ± 0.94

 − 0.235 ± 0.95

0.047

Secondary outcomes

 Postoperative bacteremia

55 (27)

25 (21)

30 (37)

0.015

 Postoperative wound infection

6 (3)

3 (3)

3 (4)

0.685

 C. difficile colitis

5 (3)

2 (2)

3 (4)

0.390

 90-d survival

197 (97)

117 (96)

80 (99)

0.405

 1-y survival

142 (89), n = 159

87 (88), n = 99

55 (92), n = 60

0.628

 Peak lactate within 72 h, mg/dL

7 ± 4, n = 188

7 ± 4, n = 113

6 ± 3, n = 75

0.002

 Stroke

6 (3)

4 (3)

2 (3)

1

 Acute rejection during hospitalization

18 (9)

12 (10)

6 (7)

0.731

 ICU LOS, d

16 ± 23

16 ± 24

17 ± 25

0.966

 Tracheostomy

44 (22)

24 (20)

20 (25)

0.499

 Airway dehiscence

5 (3)

3 (3)

2 (3)

1

 Mechanical ventilation ≥ 5 d

54 (27)

29 (24)

25 (31)

0.338

 Postoperative ECMO

22 (11)

15 (12)

7 (9)

0.556

 Readmission within 1 y

158 (89), n = 177

99 (90), n = 109

59 (87), n = 68

0.549

  1. Data reported as n (%) or mean (standard deviation)
  2. ECMO extracorporeal membrane oxygenation, ICU intensive care unit, LOS length of stay, PGD primary graft dysfunction